Outlook of the global enteric disease testing market
Technavio’s market research analyst predicts the global enteric disease testing market to grow steadily at a CAGR of around 9% during the forecast period. Recently, it has been observed that enteric diseases, such as diarrhea, cholera, and typhoid fever, are on the rise among the global population. Consequently, vendors and academics have developed an isothermal nucleic acid amplification-based diagnostic method, which incorporates all the temperature dependent steps of PCR by utilizing enzymes. Since this technology is highly specific and sensitive, healthcare facilities from across the globe can use this method to rapidly diagnose and detect pathogens. The ability of this technology to efficiently identify pathogens without the use of a thermocycler will result in this market’s impressive growth during the forecast period.
In terms of geography, the Americas accounted for about 50% of the total market share in 2015 and is envisaged to grow steadily at a CAGR of around 6% during the forecast period. Factors such as the high demand for molecular diagnostic tests and the high level of enteric disease awareness among the population will spur market growth in this region until 2020.
Disease-based segmentation of the enteric disease testing market
- Bacterial enteric diseases
- Viral enteric diseases
The bacterial enteric disease segment currently dominates this market and accounts for a market share of approximately 80% during the forecast period. The high prevalence of GI diseases, such as diarrhea and typhoid fever, will fuel the demand for bacterial enteric disease testing among patients during the forecast period.
Segmentation by type of clinical diagnosis and analysis of the enteric disease testing market
Overview of the global cancer diagnostic devices market
Technavio’s market research analyst predicts that the global cancer diagnostic devices market will grow at a significant CAGR of over 18% during the forecast period. A key market driver powering the growth of the cancer diagnostic devices market is the need for cost cutting by pharma companies. Pharmaceutical companies are shifting their focus from drug development to cancer diagnostic devices so that they can help in diagnosing, monitoring, and administering drugs through the cancer treatment process. These devices play a key role in helping pharmaceutical companies develop specific drugs to treat cancer. One such example is Roche’s cobas EGFR mutation test, which diagnoses head and neck cancers. Increased investment in diagnostic device development will boost market growth by the end of 2020.
In this industry report, the analysts estimate factors like the increased R&D spending by vendors to estimate this market’s growth potential over the forecast period. The development of nanoparticle-based theranostics is one such approach. It involves combining therapeutic and diagnostic agents and using gold nanoparticles to monitor targeted tumors in the body. This approach not only helps doctors understand the effect of drugs used to treat cancerous tumors but helps doctors to monitor their progress. The availability of such diagnostic devices will have a positive impact on market growth during the forecast period.
Product-based segmentation and analysis of the cancer diagnostic devices market
- Companion diagnostics
- Molecular diagnostics
The molecular diagnostics segment accounts for the largest share of the cancer diagnostic devices market by revenue and is expected to generate over USD 3 billion by the end of 2020. The market has significant growth
Overview of the global gonorrhea diagnostics market
Technavio’s market research analyst predicts the global gonorrhea diagnostics market to grow at a CAGR of more than 9% by 2020. There has been a recent rise in the incidences of gonorrhea across the globe due to the adoption of risky sexual behavior and unsafe sexual practices. According to the CDC, gonorrhea is the second most commonly reported communicable disease after chlamydia. The highest occurrence rates of gonorrhea are primarily in heterosexually infected men, especially those aged 25-34 years. These increasing incidences of gonorrhea will enhance the demand for gonorrhea diagnostic products during the forecast period.
The growing use of molecular diagnostics for performing gonorrhea tests is a key trend in this market. Some of the new technologies in molecular diagnostics include PCR-based techniques, nucleic acid amplification tests, and DNA nanotechnology. As a result of the high efficiency, variety, accuracy, and reliability of these gonorrhea tests, the growing use of molecular diagnostics is expected to have a positive impact on the growth of the global gonorrhea diagnostics market during the forecast period.
Segmentation by application and analysis of gonorrhea diagnostics market
- Diagnostic imaging
- Differential light scattering
- Flow cytometry
- Gel microdroplets
- Molecular diagnostics
- Monoclonal antibodies test
The molecular diagnostics procedure involves the nucleic acid extraction mixtures from gonorrhea cultures that act as a template for the diagnosis. The advancement in molecular biology has played a crucial role in the molecular
Market outlook of the global dental implants market
Technavio’s market research analyst predicts that the global dental implants market will grow steadily at a CAGR of approximately 5% by 2020. Recent technological advances in the field of implant dentistry, such as bone augmentation, 3D imaging, and mini dental implants, will propel the adoption of dental implants during the forecast period.
In this market study, analysts estimate eminent factors, such as the augmented adoption of evidence-based dentistry, to drive market growth during the predicted period. Evidence-based dentistry provides an approach to oral healthcare that follows a defined process of systematically collecting and analyzing evidence. The ability of evidence-based dentistry to aid in developing a protocol that makes dental implants more affordable will propel market growth during the forecast period.
Product-based segmentation of the dental implants market
- Titanium implants
- Zirconium implants
In this market research, Technavio analysts have estimated the titanium implants segment to be the largest market segment during the predicted period. Factors like the increasing number of oral diseases coupled with the rising awareness of oral health will lead to this segment’s profound market share of nearly 95% during the forecast period.
Geographical segmentation of the dental implants market
The EMEA region currently accounted for more than 48% of the total market share and is estimated to grow at a CAGR of nearly 5% during the forecast period. Factors such as recent advances in technology, the rise in aging population, and increasing
Outlook of the global hemoglobin testing market
According to the analysts at Technavio, the global market for hemoglobin testing will post an impressive market growth rate of almost 11% by 2020. A major factor spurring growth in this market is growing preference for direct-to-consumer testing. Direct-to-consumer testing is a growing trend in this market as most patients prefer home-care to laboratories. In this mode of testing, the individual does not need to visit laboratories or hospitals for tests as the laboratories send a professional person to the individual's doorstep to collect the blood sample with the help of collection devices. Once, the tests are performed, and results are received, the laboratory sends back the test results electronically to the individual. Advantages like the ease of testing and the availability of quick test results will lead to the high preference for direct-to-consumer testing during the forecast period.
In terms of geography, the Americas dominated this market during 2015 and is anticipated to retain its dominating hold over the market until the end of 2020 owing to the high sales of hemoglobin testing products such as analyzers and reagents and consumables. Among all the countries in this region, the market in Brazil and the US will grow rapidly due to the high demand for medical devices. Also, with the increasing preference for point-of-care testing (POCT) among patients, the prospects for growth in this market will have a positive outlook until the end of the forecast period.
Technology-based segmentation and analysis of the hemoglobin testing market
During 2015, the chromatography technology segment dominated this market by accounting for a market share of approximately 50%. Affinity chromatography, high-performance liquid chromatography (HPLC), and cation-exchange
Overview of the global transplant diagnostics market
Technavio’s market research analyst predicts the global transplant diagnostics market to grow at a CAGR of more than 6% by 2020. Various governmental and non-governmental organizations are conducting awareness programs to spread the knowledge about organ transplantation. Awareness of organ donation can help meet the demand for the number of required transplantation. Though many people support the cause, very few donate organs. Organizations need to spread awareness about the benefits of organ transplantation to meet the demand for a donor organ and reduce the mortality rate. Rise in public awareness of organ donation will boost the growth prospects of this market during the forecast period.
The growing demand and increasing use of transplant diagnostics have propelled several manufacturers to come up with new products in the market. Most of these new products introduced have received regulatory approvals, particularly FDA approval, and are accessible to both individuals and medical personnel. For instance, ThermoFisher Scientific introduced the NXType NGS HLA typing assay that includes molecular typing products such as SSO, SSP, and SBT technologies. Recently, Illumina introduced Conexio's HLA typing solutions that allow researchers to analyze genomic variants that cause complications during transplants.
Segmentation by screening and analysis of the transplant diagnostics market
- Pre-transplant diagnostics
- Post-transplant diagnostics
The post-transplant diagnostics segment dominated the market in 2015 and accounted for more than 59% of the total market share. The use of post-transplant diagnostics is high as many people undergo regular biopsies in the initial months after organ transplantation. The most popular device for carrying out this procedure is AlloMap system which can be used
In-vitro diagnostics is one of the fastest-growing sectors in healthcare. Cost-containment strategies by healthcare entities have led to an increased focus on early diagnosis, preventive medicine, and personalized medicine.
This move towards preventive and personalized medicine is driving the adoption of in-vitro diagnostics, and vendors are focusing on developing tests for a wide range of applications for hospitals and laboratories, as well as for home care. The presence of a high number of market participants has significantly intensified competition.